Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MTS2: Atropine and HAL Spectacles for Myopia in Children
NCT07095894Phase 3Recruiting
- Sponsor
- Jaeb Center for Health Research
- Start
- Jul 2026
- Primary completion
- Jul 2029
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of NVK002 in myopia, sponsored by Jaeb Center for Health Research. Started Jul 2026; status: recruiting.
02
Drugs
NVK002
03
Conditions
myopia
Beyond the preview
Go deeper on NCT07095894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07095894.